FARCO-PHARMA GMBH (Germany) holds 1 active US FDA Type II Drug Master File. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “FARCO-PHARMA GMBH: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/farco-pharma-gmbh

Overview

FARCO-PHARMA GMBH is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering DRUG PRODUCT MANUFACTURING FACILITY FOR GLYDO® (LIDOCAINE HCL USP) 2% TOPICAL JELLY.

API / Drug Master Files

FARCO-PHARMA GMBH holds 1 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • DRUG PRODUCT MANUFACTURING FACILITY FOR GLYDO® (LIDOCAINE HCL USP) 2% TOPICAL JELLYActive2025-08-18

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to FARCO-PHARMA GMBH in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this FARCO-PHARMA GMBH?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.